Unlock stock picks and a broker-level newsfeed that powers Wall Street.

HKSE - Delayed Quote HKD

Broncus Holding Corporation (2216.HK)

2.450
+0.580
+(31.02%)
At close: April 25 at 4:08:21 PM GMT+8
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
10,255
10,255
9,413
10,891
3,259
Cost of Revenue
3,028
3,028
2,098
2,149
753
Gross Profit
7,227
7,227
7,315
8,742
2,506
Operating Expense
40,548
40,548
39,088
46,171
23,075
Operating Income
-33,321
-33,321
-31,773
-37,429
-20,569
Net Non Operating Interest Income Expense
5,878
5,878
2,530
-9
-571
Pretax Income
-28,089
-28,089
-28,033
-236,175
-48,784
Tax Provision
3
3
3
3
2
Net Income Common Stockholders
-28,091
-28,091
-28,036
-235,784
-48,237
Diluted NI Available to Com Stockholders
-28,091
-28,091
-28,036
-235,784
-48,237
Basic EPS
-0.06
-0.06
-0.06
-0.79
-0.09
Diluted EPS
-0.06
-0.06
-0.06
-0.79
-0.09
Basic Average Shares
488,208.953
488,570.732
487,749.376
298,960.470
525,616.784
Diluted Average Shares
488,208.953
488,570.732
487,749.376
298,960.470
525,616.784
Total Expenses
43,576
43,576
41,186
48,320
23,828
Net Income from Continuing & Discontinued Operation
-28,091
-28,091
-28,036
-235,784
-48,237
Normalized Income
-28,192.250
-28,192.250
-28,354.750
-236,181.500
-48,561
Interest Income
6,041
6,041
2,628
161
76
Interest Expense
163
163
98
170
647
Net Interest Income
5,878
5,878
2,530
-9
-571
EBIT
-27,926
-27,926
-27,935
-236,005
-48,137
EBITDA
-25,060
-25,060
-25,087
-233,314
-45,945
Reconciled Cost of Revenue
3,028
3,028
2,098
2,149
753
Reconciled Depreciation
2,866
2,866
2,848
2,691
2,192
Net Income from Continuing Operation Net Minority Interest
-28,091
-28,091
-28,036
-235,784
-48,237
Total Unusual Items Excluding Goodwill
135
135
425
530
432
Total Unusual Items
135
135
425
530
432
Normalized EBITDA
-25,195
-25,195
-25,512
-233,844
-46,377
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
33.750
33.750
106.250
132.500
108
12/31/2020 - 9/24/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

6609.HK Shanghai HeartCare Medical Technology Corporation Limited
27.900
+2.20%
 
2393.HK Yestar Healthcare Holdings Company Limited
0.082
+2.50%
 
2190.HK Zylox-Tonbridge Medical Technology Co., Ltd.
18.580
-2.93%
 
2160.HK MicroPort CardioFlow Medtech Corporation
0.930
+1.09%
 
9996.HK Peijia Medical Limited
5.410
-1.81%
 
CATX Perspective Therapeutics, Inc.
2.3900
-1.65%
 
RBOT Vicarious Surgical Inc.
8.47
+27.37%
 
NVCR NovoCure Limited
18.50
-0.27%
 
PRCT PROCEPT BioRobotics Corporation
52.49
-0.13%
 
BSX Boston Scientific Corporation
101.90
+0.75%